Novo Integrated Sciences, Inc. NVOS OTC

Other OTC • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score

27/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Novo Integrated Sciences, Inc. (NVOS) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 25/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

27/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✗

健康

33/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

43/100

→ Income

成长

48/100

→ Income

✗

收入

10/100

→ Income

估值概览 — NVOS

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.89

每股账面价值$0.00

每股营收$0.74

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2015	$-13.29	$7.47M	$-2.77M	-37.1%
2016	$-0.74	$7.18M	$-164.89K	-2.3%
2017	$-0.42	$7.96M	$-738.38K	-9.3%
2018	$-1.02	$8.89M	$-2.11M	-23.7%
2019	$-0.18	$9.42M	$-391.98K	-4.2%
2020	$-2.13	$7.86M	$-4.92M	-62.5%
2021	$-1.80	$9.31M	$-4.46M	-48%
2022	$-11.28	$11.74M	$-32.85M	-279.9%
2023	$-1.30	$12.57M	$-13.21M	-105.1%
2024	$-0.89	$13.29M	$-16.13M	-121.3%